Code | Name | Description |
---|---|---|
DM | Demographics | Subject demographics and characteristics |
SE | Subject Elements | Planned protocol elements for each subject |
SV | Subject Visits | Subject visit dates and related information |
CO | Comments | Comments and narrative information |
AE | Adverse Events | Adverse events reported during the study |
MH | Medical History | Subject-relevant medical history |
DS | Disposition | Subject disposition information including completion/discontinuation |
HO | Hospitalization | Data related to hospitalization during the study |
DD | Death Details | Details related to subject deaths |
CM | Concomitant Medications | Medications taken during the study period |
EX | Exposure | Exposure to protocol-specified study treatment |
PR | Procedures | Procedures performed during the study |
DA | Drug Accountability | Accountability of study drug dispensation and return |
VS | Vital Signs | Vital signs measurements taken during the study |
LB | Laboratory Tests | Laboratory test results |
EG | Electrocardiogram | Electrocardiogram test results |
PE | Physical Exam | Physical examination findings |
QS | Questionnaire | Questionnaire and patient-reported outcomes |
FA | Findings About | Findings about other domains |
MB | Microbiology Specimen | Microbiological specimen data |
TU | Tumor Identification | Identification of target/non-target tumors and lesions |
TR | Tumor Response | Tumor response evaluations |
SS | Subject Status | Status and condition information about the subject |
IE | Inclusion/Exclusion Criteria Not Met | Details about inclusion/exclusion criteria not met |
PK | Pharmacokinetics | Pharmacokinetic analysis results |
PD | Pharmacodynamics | Pharmacodynamic measurements and analysis |